Randomized, sham-controlled, multicenter, pragmatic, trial with open-label extension of PHOENIX to improve glycemic control in adults with type 2 diabetes in a real-world setting

Primary Objective

- To evaluate the efficacy and safety of the digital therapeutic, Phoenix, to improve HbA1c at three (3) and six (6) -months compared to a control group. - To evaluate the long-term effectiveness and impact on health care utilization and medication use between study groups in real-world clinical practice over a pragmatic extension period of an additional 18 months.

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Type of Study

Treatment

Scope

National

Locations

Memorial Hospital Central

Study ID

Protocol Number: 22-0315

More information available at ClinicalTrials.gov: NCT05266625

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers